- Related News
All posts tagged Aureos
Fund differentiation will be critical on Africa’s increasingly competitive fundraising trail in 2013, as the bulk of industry leaders tout follow-on funds and new GPs market maiden vehicles. . Getting Limited Partners (LPs) to commit to a private equity vehicle …
Abraaj Group has invested in Vine Pharmaceuticals, a Uganda-based health care products retailer. The financial details have not been disclosed.
Exits volumes in the African private equity industry hit a record high in 2012, bolstered by sales to trade buyers, according to Preqin data.
Private equity sellers delivered
Aureos Capital has invested $1.7million worth of growth capital into Togo-based private medical services provider, Clinique Biasa. The funding will help Clinique Biasa complete its $5million growth and upgrade
Private Equity Africa is delighted to announce the winners of its maiden awards. The accolades are the first and only awards to solely focus on Africa’s private equity industry. The
Aureos has exited Zambia-based agribusiness Golden Lay to Phatisa for $24 million, through a leveraged buyout deal. Phatisa, through its African Agriculture Fund (AAF) , is investing in the
Aureos has sold its stake in South Africa-based bricks and construction aggregates manufacturing company SA Block, in a trade sale to Afrimat. The exit brings to an end the
Aureos has backed Nigeria-based fertility health care company Therapia Health with $5million. Therapia is the holding company for the Bridge Clinic, which is understood to be first assisted reproductive
Aureos Capital has become the latest private equity investor to come under the hammer as it is sold to Middle-East giant Abraaj Capital. The financial details of the transaction
Aureos’s Africa Health Fund (AHF) has reached a final close at $105.4m, exceeding the $100million the manager set for the fund. AHF is a specialist pilot fund anchored by